-
28-09-2020, 10:28 AM
#17061
Who believes this will be the only downgrade. A2 is a very good company but I reckon that H2 forecast looks pretty aggressive and there will likely be more average news the next 6 months and maybe a pullback to $10-$12. I don't own so might be being hopeful of a nice entry point longer term but companies very very rarely have one downgrade...
-
28-09-2020, 10:30 AM
#17062
Originally Posted by Arbroath
Who believes this will be the only downgrade. A2 is a very good company but I reckon that H2 forecast looks pretty aggressive and there will likely be more average news the next 6 months and maybe a pullback to $10-$12. I don't own so might be being hopeful of a nice entry point longer term but companies very very rarely have one downgrade...
Balance reckons downgrades always come in 3's !
I agree, 2H sales forecast looks "hopeful" to me.
Last edited by Beagle; 28-09-2020 at 10:40 AM.
Ecclesiastes 11:2: Divide your portion to seven, or even to eight, for you do not know what misfortune may occur on the earth.
Ben Graham - In the short run the market is a voting machine but in the long run the market is a weighing machine
-
28-09-2020, 10:30 AM
#17063
Originally Posted by Arbroath
Who believes this will be the only downgrade. A2 is a very good company but I reckon that H2 forecast looks pretty aggressive and there will likely be more average news the next 6 months and maybe a pullback to $10-$12. I don't own so might be being hopeful of a nice entry point longer term but companies very very rarely have one downgrade...
agree totally
one step ahead of the herd
-
28-09-2020, 10:45 AM
#17064
Originally Posted by Left field
It's not just MF.....
Goldman Sachs is forecasting earnings before interest, tax, depreciation and amortisation ( EBITDA) of NZ$662 million in FY 2021. This will be a 19.9% increase on FY 2020s EBITDA of NZ$552 million.
On the bottom line, it has penciled in earnings per share of NZ$0.63, up 20% from NZ$0.524 a year earlier.
In light of this growth and the recent pullback in the a2 Milk share price, Goldman thinks the company is trading at a very attractive level.
It explained: ATM is (currently) trading at an FY21 P/E of 17.9X, a 6% premium to the market compared to its five-year average of a 50% premium.
On top of that GS projected 20% revenue increase for FY21 is conservative IMHO. I estimate a 25% increase.
As Cgcc points out, it is all about the longer term and ATM outperforming the NZX50 average.
ATM's record in this respect for the last 5 yrs is impeccable. (NZX 50 up about 100%, while ATM up 2400%....NZX is the black line at the foot of this graph.)
Attachment 11969
Look's like we cant rely on Motley Fool or GS.
Where, or who to next?
-
28-09-2020, 10:56 AM
#17065
They still are generating heaps of cash and have a very attractive market position.
It seems fairly priced around these levels, but lets see what aussie brings. Imagine $15nzd is a possibility end of day.
-
28-09-2020, 10:59 AM
#17066
Originally Posted by JeremyALD
They still are generating heaps of cash and have a very attractive market position.
It seems fairly priced around these levels, but lets see what aussie brings. Imagine $15nzd is a possibility end of day.
be a sustained re- rating now. must also remember the chinese govt is promoting domestic owned companies big time now
one step ahead of the herd
-
28-09-2020, 11:00 AM
#17067
Member
Originally Posted by tomm
Topping up opportunities. Things are still up. Please sell....The Ausie will scoop it up. No worries
Notwithstanding the significant uncertainty and volatility in market |
conditions as a result of COVID-19 we have determined it appropriate to |
provide an update to our outlook to include our view of Group revenue as |
follows: |
- Group revenue for 1H21 of $725 million to $775 million |
- Group revenue for FY21 of $1.80 billion to $1.90 billion |
- Group EBITDA margin for FY21 in the order of 31%. |
It should be noted that the sale of infant formula through the daigou channel |
is only one component of our multi-channel and multi-product sales strategy |
into China. Our growth plan assumes MBS and CBEC sales will represent an |
increasing proportion of our infant nutrition business over time, driven by |
the continuing growth in underlying consumer demand. |
I would like to see how they start growth stage 2, (stage 1 clearly completed, establishment of brand name)
- playing with Chinese online giants, Dj.com, Taobao and T-mall
- SEM
- live delivery ( popular way nowadays, an internet celebrity can sell millions $ just within 10-15 mins)
- some supermarket distribution channel
Those channels are far more bigger than Daigou private channel.
-
28-09-2020, 11:09 AM
#17068
Obviously plenty on here hoping for more juicy drops so they can buy in. Beware of their motivations before you listen too closely folks!
-
28-09-2020, 11:12 AM
#17069
Member
After ASX opens, A2 will have its final hit, then it is the best time to sneak into the show.
-
28-09-2020, 11:16 AM
#17070
hammertime big portfolio sells will come out during the week
one step ahead of the herd
Tags for this Thread
Posting Permissions
- You may not post new threads
- You may not post replies
- You may not post attachments
- You may not edit your posts
-
Forum Rules
|
|
Bookmarks